Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Positive effects of methylphenidate on social communication and self-regulation in children with pervasive developmental disorders and hyperactivity.

Jahromi LB, Kasari CL, McCracken JT, Lee LS, Aman MG, McDougle CJ, Scahill L, Tierney E, Arnold LE, Vitiello B, Ritz L, Witwer A, Kustan E, Ghuman J, Posey DJ.

J Autism Dev Disord. 2009 Mar;39(3):395-404. doi: 10.1007/s10803-008-0636-9. Epub 2008 Aug 28.

2.

Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.

Research Units on Pediatric Psychopharmacology Autism Network..

Arch Gen Psychiatry. 2005 Nov;62(11):1266-74.

PMID:
16275814
3.

Parent-rated anxiety symptoms in children with pervasive developmental disorders: frequency and association with core autism symptoms and cognitive functioning.

Sukhodolsky DG, Scahill L, Gadow KD, Arnold LE, Aman MG, McDougle CJ, McCracken JT, Tierney E, Williams White S, Lecavalier L, Vitiello B.

J Abnorm Child Psychol. 2008 Jan;36(1):117-28. Epub 2007 Aug 3.

PMID:
17674186
4.

Positive effects of methylphenidate on inattention and hyperactivity in pervasive developmental disorders: an analysis of secondary measures.

Posey DJ, Aman MG, McCracken JT, Scahill L, Tierney E, Arnold LE, Vitiello B, Chuang SZ, Davies M, Ramadan Y, Witwer AN, Swiezy NB, Cronin P, Shah B, Carroll DH, Young C, Wheeler C, McDougle CJ.

Biol Psychiatry. 2007 Feb 15;61(4):538-44.

PMID:
17276750
5.

Methylphenidate for pervasive developmental disorders: safety and efficacy of acute single dose test and ongoing therapy: an open-pilot study.

Di Martino A, Melis G, Cianchetti C, Zuddas A.

J Child Adolesc Psychopharmacol. 2004 Summer;14(2):207-18.

PMID:
15319018
6.

Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism.

King BH, Hollander E, Sikich L, McCracken JT, Scahill L, Bregman JD, Donnelly CL, Anagnostou E, Dukes K, Sullivan L, Hirtz D, Wagner A, Ritz L; STAART Psychopharmacology Network..

Arch Gen Psychiatry. 2009 Jun;66(6):583-90. doi: 10.1001/archgenpsychiatry.2009.30.

7.

Efficacy of methylphenidate among children with autism and symptoms of attention-deficit hyperactivity disorder.

Handen BL, Johnson CR, Lubetsky M.

J Autism Dev Disord. 2000 Jun;30(3):245-55.

PMID:
11055460
8.

Children's Yale-Brown Obsessive Compulsive Scale modified for pervasive developmental disorders.

Scahill L, McDougle CJ, Williams SK, Dimitropoulos A, Aman MG, McCracken JT, Tierney E, Arnold LE, Cronin P, Grados M, Ghuman J, Koenig K, Lam KS, McGough J, Posey DJ, Ritz L, Swiezy NB, Vitiello B; Research Units on Pediatric Psychopharmacology Autism Network..

J Am Acad Child Adolesc Psychiatry. 2006 Sep;45(9):1114-23.

PMID:
16926619
9.
10.

Methylphenidate an effective treatment for ADHD?

McDougle CJ.

J Autism Dev Disord. 2004 Oct;34(5):593-4. No abstract available.

PMID:
15628613
11.

A prospective open trial of guanfacine in children with pervasive developmental disorders.

Scahill L, Aman MG, McDougle CJ, McCracken JT, Tierney E, Dziura J, Arnold LE, Posey D, Young C, Shah B, Ghuman J, Ritz L, Vitiello B.

J Child Adolesc Psychopharmacol. 2006 Oct;16(5):589-98.

PMID:
17069547
12.
13.

Pharmacological treatment options for autism spectrum disorders in children and adolescents.

Leskovec TJ, Rowles BM, Findling RL.

Harv Rev Psychiatry. 2008;16(2):97-112. doi: 10.1080/10673220802075852. Review.

PMID:
18415882
14.

Academic, behavioral, and cognitive effects of OROSĀ® methylphenidate on older children with attention-deficit/hyperactivity disorder.

Wigal SB, Wigal T, Schuck S, Brams M, Williamson D, Armstrong RB, Starr HL.

J Child Adolesc Psychopharmacol. 2011 Apr;21(2):121-31. doi: 10.1089/cap.2010.0047. Epub 2011 Apr 13.

15.

A comparison of ritalin and adderall: efficacy and time-course in children with attention-deficit/hyperactivity disorder.

Pelham WE, Aronoff HR, Midlam JK, Shapiro CJ, Gnagy EM, Chronis AM, Onyango AN, Forehand G, Nguyen A, Waxmonsky J.

Pediatrics. 1999 Apr;103(4):e43.

PMID:
10103335
16.

Use of methylphenidate in the treatment of children with autistic disorder.

Quintana H, Birmaher B, Stedge D, Lennon S, Freed J, Bridge J, Greenhill L.

J Autism Dev Disord. 1995 Jun;25(3):283-94.

PMID:
7559293
17.
18.

Randomized, placebo-controlled, crossover study of methylphenidate for attention-deficit/hyperactivity disorder symptoms in preschoolers with developmental disorders.

Ghuman JK, Aman MG, Lecavalier L, Riddle MA, Gelenberg A, Wright R, Rice S, Ghuman HS, Fort C.

J Child Adolesc Psychopharmacol. 2009 Aug;19(4):329-39. doi: 10.1089/cap.2008.0137.

19.

Effects of risperidone and parent training on adaptive functioning in children with pervasive developmental disorders and serious behavioral problems.

Scahill L, McDougle CJ, Aman MG, Johnson C, Handen B, Bearss K, Dziura J, Butter E, Swiezy NG, Arnold LE, Stigler KA, Sukhodolsky DD, Lecavalier L, Pozdol SL, Nikolov R, Hollway JA, Korzekwa P, Gavaletz A, Kohn AE, Koenig K, Grinnon S, Mulick JA, Yu S, Vitiello B; Research Units on Pediatric Psychopharmacology Autism Network..

J Am Acad Child Adolesc Psychiatry. 2012 Feb;51(2):136-46. doi: 10.1016/j.jaac.2011.11.010. Epub 2011 Dec 23.

20.

A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder.

Stein MA, Sarampote CS, Waldman ID, Robb AS, Conlon C, Pearl PL, Black DO, Seymour KE, Newcorn JH.

Pediatrics. 2003 Nov;112(5):e404.

PMID:
14595084

Supplemental Content

Support Center